Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Supply chain

Ranitidine among drugs added to export ban

The Department of Health and Social Care has added our more medicines to list of those that cannot be parallel exported from the UK.

Ranitidine, alprostadil, beclometasone dipropionate and norethisterone have been banned from parallel exportation as of 18 October.

Earlier in October 2019, the government issued guidance on restrictions banning wholesalers from parallel exporting 23 products, including 19 hormone replacement products, as well as some adrenaline auto-injectors and hepatitis B vaccines.

Manufacturers or wholesalers who are found guilty of parallel exporting of one or more of the listed medicines may face regulatory action by the Medicines and Healthcare products Regulatory Agency, including the immediate suspension of their wholesale dealer licence.

When the original parallel exporting restriction was published, Martin Sawer, executive director of the Healthcare Distribution Association, which represents wholesalers, said its member companies believed that a small number of firms holding a wholesale dealer licence may be buying small amounts of stock from several locations and then exporting aggregated packs of these medicines.

Pharmacists had previously been advised to stop supplying some ranitidine products after it was revealed that they may be contaminated with the impurity N-nitrosodimethylamine. The European Medicines Agency announced that it would start a review of ranitidine medicines in September 2019 after tests revealed some products could contain the impurity.


Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207217

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.